نتایج جستجو برای: sustained virologic response svr

تعداد نتایج: 1046149  

Journal: :Gastroenterology & hepatology 2012
Joseph S Galati

JSG The chance of clearing the virus and achieving a sustained virologic response (SVR) nearly doubled with the addition of these protease inhibitors. This improvement gave many people in the field of medicine a sense of renewal, as we finally have new agents to add to the interferon and ribavirin regimen that was the standard treatment for hepatitis C virus (HCV) infection for more than 10 years.

2013
Young-Joo Jin Jin-Woo Lee Jung il Lee Sang Hoon Park Choong Kee Park Young Seok Kim Sook-Hyang Jeong Yun Soo Kim Ju Hyun Kim Seong Gyu Hwang Kyu Sung Rim Hyung Joon Yim Jae Youn Cheong Sung Won Cho June Sung Lee Young Min Park Jeong Won Jang Chun Kyon Lee Joo Hyun Sohn Jin Mo Yang Seungbong Han

BACKGROUND Two recent Italian studies suggested that Pegylated-interferon (PEG-IFN) alfa-2a achieves a higher sustained virological response (SVR) rate than PEG-IFN alfa-2b. We intended to compare the efficacy and safety of PEG-IFN alfa-2a with those of PEG-IFN alfa-2b in Korean patients with chronic hepatitis C virus (HCV). METHODS This retrospective, multi-center trial was conducted on 661 ...

2012
Danielle Brandman Peter Bacchetti Claudia E. Ayala Jacquelyn J. Maher Mandana Khalili

OBJECTIVE Insulin resistance, as measured by surrogate markers, is associated with lower response to hepatitis C virus (HCV) therapy and may improve with HCV eradication. We prospectively evaluated the impact of directly measured insulin resistance and abnormal glucose metabolism on achieving sustained virologic response (SVR) with HCV therapy and assessed whether SVR results in improved insuli...

2015
Suh Yoon Yang Hyun Woong Lee Youn Jae Lee Sung Jae Park Ki Young Yoo Hyung Joon Kim

BACKGROUND/AIMS Chronic hepatitis C (CHC) is a major comorbidity in patients with hemophilia. However, there are no published data on the efficacy of antiviral therapy in Korea. We assessed the safety and efficacy of combination therapy with peginterferon α-2a plus ribavirin for CHC in hemophilia. METHODS Patients (n=115) were enrolled between March 2007 and December 2008. Seventy-seven patie...

2012
Yeon Joo Kim Sung Bum Cho Sang Woo Park Hyoung Ju Hong Du Hyeon Lee Eun Ae Cho HyunSoo Kim Sung Kyu Choi Jong Sun Rew

Pegylated-interferon plus ribavirin is the standard treatment for chronic hepatitis C. Sustained virological response (SVR) rates of up to 80% are reported in genotype 2 and 3 chronic hepatitis C cases. Obesity, a modifiable risk factor, may have a deleterious effect on antiviral treatment. We performed this study to examine the efficacy and safety of pegylated-interferon and ribavirin therapy ...

Journal: :The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2010
Sandro da Costa Ferreira Marcos de Vasconcelos Carneiro Fernanda Fernandes Souza Andreza Corrêa Teixeira Marcia Guimarães Villanova José Fernando de Castro Figueiredo Afonso Dinis Costa Passos Leandra Naira Zambelli Ramalho Sergio Zucoloto Ana de Lourdes Candolo Martinelli

BACKGROUND AND AIM The durability of the sustained virologic response (SVR) in patients with chronic hepatitis C after treatment and the ideal follow-up time for these patients remains undefined. The objective of the study was to evaluate the durability of the virologic response in patients with chronic hepatitis C followed up for at least 12 months after SVR at HCFMRP-USP. METHODS The study ...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013
Eric Druyts Kristian Thorlund Ping Wu Steve Kanters Sanni Yaya Curtis L Cooper Edward J Mills

BACKGROUND A systematic review and meta-analysis were conducted to examine the efficacy and safety of pegylated interferon (peg-IFN) alfa-2a and peg-IFN alfa-2b plus ribavirin (RBV) in children and adolescents with chronic hepatitis C virus (HCV). METHODS Medline, Embase, and Cochrane Central Register of Controlled Trials were searched. Clinical trials examining peg-IFN alfa-2a or peg-IFN alf...

Background: Nowadays, the immune response to hepatitis C (HCV) treatment has become a crucial issue mostly due to the interleukin 28B (IL-28B) polymorphism effects in chronic HCV patients. The aim of this study was to detect the polymorphism of IL-28B gene (rs12979860) in HCV genotype 1 patients treated with pegylated Interferon and Ribavirin. Methods...

2015
Salwa H. Gomaa Ahmed Abdel Mohsen Hanan Mostafa Mostafa Mohamed Abd El Rahman Ahmed

Egypt has the highest hepatitis C virus (HCV) prevalence in the world, it has been reported that 14.7% of Egyptian population is chronically infected with HCV and 90% of them are genotype-4 (El-Zanaty et al, 2011) and (Guerra et al, 2012). Up to now, the standard of care (SOC) treatment of chronic HCV infection consists of (pegylated) interferon-Alpha and oral ribavirin. (Hendy et al, 2011). Th...

2012
Huy A Tran Tracey L Jones Elizabeth A Ianna Robert A Gibson Glenn E M Reeves

BACKGROUND Single nucleotide polymorphism in the interleukin28B (IL28B) gene was recently shown to be associated with a significant increase in response to interferon-α and ribavirin treatment in patients with chronic hepatitis C. Similarly, thyroid disease (TD) occurring during treatment confer an improved sustained virologic response (SVR). OBJECTIVES To determine the role of IL28B genotype...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید